跳至主要内容
临床试验/IRCT20181029041490N1
IRCT20181029041490N1已完成2 期

The effect of Resveratrol supplement on metabolic profiles and genes expression of Sirtuin-1? TNF-a? TGF-ß? IL-1? PPAR? in diabetetic coronary artery disease patients

Kashan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 85 years(—)
性别
All

入选标准

  • patients with T2DM, aged 40-85 years old with proven 2- and 3-vessel CHD

排除标准

  • Consuming resveratrol three months prior to the intervention
  • Taking antioxidant and/or anti-inflammatory supplements such as vitamin E and vitamin C
  • Having an acute myocardial infarction or cardiac surgery in the past three months
  • Having renal or hepatic failure

研究者

相似试验